Posts Tagged galvanic spa
New Online Prospecting System For Nu Skin Distributors
Posted by admin in Uncategorized on February 7, 2010
AgeLOC Launches In Japan as “GenLOC”
Posted by admin in ageloc, galvanic spa, genloc, nse, nu skin, nu skin enterprises, nuskin, skin care on December 21, 2009
PROVO, Utah— Nu Skin Enterprises Inc. introduced its ageLOC Future Serum to more than 10,000 sales reps at its launch in Japan; the product line is marketed as “genLOC” in Japan. The anti-aging serum is designed to preserve the skin and reduce the appearance of aging.
Truman Hunt, president and CEO, said: “We continue to believe that ageLOC will be the biggest global product launch in Nu Skin history and are pleased to begin the roll out in Japan. We are committed to fueling the positive trends we are seeing in Japan and believe that the introduction of ageLOC will help in generating distributor enthusiasm in this important market. Our proprietary ageLOC products enable our sales representatives to take advantage of the accelerating growth in the anti-aging industry, which is expected to grow by 73 percent in Japan by 2015. We’ll continue the global roll out of ageLOC next month as we launch new ageLOC skin care products in the United States, Europe and Latin America.”
Nu Skin Japan also announced Makoto Kuro-O, M.D., Ph.D., associate professor of pathology at the University of Texas Southwestern Medical Center, as a new member of its Anti-Aging Scientific Advisory Board. Dr. Kuro-O will also serve as the chairman of the Nu Skin Japan Scientific Advisory Board, providing his insights on gene-based anti-aging science.
What AgeLOC Is…
Posted by admin in ageloc, arnox, ethocyn, galvanic spa, nse, nu skin, nu skin enterprises, nuskin, skin care, tru face essence on July 14, 2009
·
· Nu Skin Enterprises’ platform to become the world’s leading anti-aging company
· Nu Skin’s Competitive Advantage: other companies focus on the signs of aging (lines, wrinkles, etc.). ageLOC attacks both the signs and the sources of aging
· There are many sources of aging, but the ultimate source of aging is found in our genes
· Virtually everything we encounter influences our genes: diet, stress, sleep, pollution, smoking, etc. Until recently, science has not be able to understand how nutrition and skincare products influence our genes
· Nu Skin has aggregated unique, proprietary ways to isolate clusters of genes that are critical to the aging process
· With proprietary formulas, Nu Skin’s ageLOC products will help to reset and support “Youth Gene Clusters,” the genes that help to preserve youthfulness—leading to preventative and corrective benefits
· Products developed in consideration of the impact they have on genes will likely be safer than those developed with no regard for the impact of that product on genes
· Galvanic Spa gels include ageLOC ingredients to battle arNOX, a source of aging identified by Nu Skin research over the past 4 years
· A daily use ageLOC skincare regimen containing a broader spectrum of ageLOC ingredients focused on genes will launch in October
· In the future, additional Nu Skin and Pharmanex products will be infused with other ageLOC ingredients to battle aging at the ultimate source—our genes.
· In the future, it is almost certain that other companies will try to mimic Nu Skin’s approach to product development
NEW AgeLOC Business Opportunity Video
Posted by admin in ageloc, arnox, galvanic spa, nu skin, nu skin enterprises, nuskin on June 28, 2009
AgeLOC LAUNCHES!!
Nu Skin Sales Leaders Poised To Capitalize on Promising Megatrends
PROVO, Utah, June 22 /PRNewswire/ — Top international sales leaders for Nu Skin Enterprises, Inc. gathered today in Saint Petersburg, Russia, to learn how Nu Skin plans to expand its distributor business opportunity with next-generation anti-aging products in both skin care and nutrition that target the ultimate sources of aging.
To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/nuskin/38868/
“For more than 25 years, Nu Skin has offered people the opportunity to start their own business selling exclusive and innovative anti-aging products — and that opportunity will be better than ever with ageLOC,” said Truman Hunt, Nu Skin president and chief executive officer. “We believe that ageLOC is unlocking the secret of youth through our unique understanding of the relationship between aging and certain genes in the human genome, the ultimate sources of aging.
“ageLOC will not only have significant implications for an aging population that wants to live young, but also for an increasing number of people who are seeking out Nu Skin’s business opportunity to supplement or replace their income.”
The international sales meeting is the next step in the company’s roll out of its exclusive ageLOC discoveries. Nu Skin introduced the first phase of its strategy to target the sources of aging last October with the launch of ageLOC Galvanic Spa Facial Gels, formulated to target a free radical generator in the skin to deliver superior cosmetic benefits. The company will continue its roll out of ageLOC products with the introduction of an unmatched daily skin care system this October at Nu Skin’s global 25th anniversary celebration in Los Angeles. As part of its strategic direction, the company will also unveil plans to launch additional exclusive ageLOC products, including a nutritional supplement in the latter half of 2010.
“By targeting the ultimate sources of aging we have the advantage of developing truly game-changing products that have both preventative and corrective anti-aging benefits,” said Joe Chang, Nu Skin executive vice president and chief scientific officer. “ageLOC also unites our skin care and nutritional product lines into a comprehensive anti-aging product offering that delivers solutions for people who want to enjoy a more youthful existence.”
THE ageLOC OPPORTUNITY: Leveraging Socio-Economic Megatrends
ageLOC is a powerful platform for Nu Skin distributors as they continue to benefit from significant social and economic megatrends, including a growing aging population and an increase in those seeking ways to supplement or replace income. For example, by 2030 the number of people worldwide over the age of 60 is expected to double to more than 1 billion. By 2015, the anti-aging industry is expected to grow 76 percent in the United States, 73 percent in Japan and 82 percent in the Asia Pacific region. Additionally, the economic environment bodes well for Nu Skin’s direct selling business model as Nu Skin offers an attractive option for those who need to supplement or replace their income in today’s harsh economy.
“Nu Skin continues to stay relevant by marketing innovative and scientifically validated products, as well as by paying the highest percentage of revenue in distributor commissions of all direct selling companies listed on the New York Stock Exchange,” said Ashok Pahwa, chief marketing officer at Nu Skin. “That is especially meaningful considering the fact that 2008 was the largest revenue year in Nu Skin’s 25-year history with $1.25 billion in sales.”
Anti-Age Product Could Lift Nu Skin; Dividend Rising
INVESTOR’S BUSINESS DAILY
A new product, if successful, can accelerate sales and earnings growth.
Utah-based Nu Skin Enterprises (NUS) plans to roll out an anti-aging product in January that, if not a fountain of youth, might be at least a sprinkler of youth.
Professors at Purdue University and the Stanford School of Medicine, along with Nu Skin researchers, discovered an enzyme that affects a person’s appearance.
According to a study conducted at Stanford, people with high levels of arNox, the enzyme, look about seven years older than those with low levels of it.
Nu Skin’s new product ageLoc contains an ingredient that the company says can inhibit the enzyme.
If it works, the next question is how much it can boost the bottom line of this direct seller of personal care and nutrition supplements.
Nu Skin sees great potential in the new product.
“This is a platform change for us,” Chief Executive Truman Hunt told IBD on Wednesday. “The market is not yet focused on where we are.”
Most anti-aging products focus on masking symptoms. Hunt said ageLoc is addressing the source.
Apart from the new product, Nu Skin has some features attractive to income investors.
It has paid dividends since 2001 and increased the payout seven straight years.
Nu Skin Science Unlocks a Secret
Posted by admin in ageloc, arnox, galvanic spa, nuskin on October 26, 2008
PROVO, Utah · Oct. 23, 2008 /PRNewswire/ — Current anti-aging products merely address the superficial signs of aging, like wrinkling and skin texture, but today Nu Skin Enterprises, Inc. (NYSE:NUS) introduces its breakthrough anti-aging ageLOC™ technology that when incorporated into Nu Skin’s skin care lineup not only slows a newly discovered age-causing enzyme at its source, but also demonstrates visible benefits in the form of smoother, brighter, more youthful-looking skin. “Consumers in every economic category are spending money on anti-aging products, whether it’s for a $30 jar of cream or invasive treatments costing thousands of dollars, but no solution has yet to do what ageLOC technology offers,” said Ashok Pahwa, chief marketing officer at Nu Skin Enterprises. “We believe ageLOC technology will propel Nu Skin to the forefront of the anti-aging industry by attacking aging where it is happening, before you even see it. Our science is unlocking a secret to how you age.” This first-to-market anti-aging technology from Nu Skin is the result of more than six years of research and development. ageLOC employs a patent-pending ingredient blend to help diminish the negative visible effects caused by a newly discovered internal source of aging and offers a scientific explanation to why some people may look younger or older than their actual age. Revolutionary ageLOC technology will first be available in the reformulated Nu Skin Galvanic Spa Facial Gels. The Nu Skin Galvanic Spa System II is currently the company’s best-selling product line in several markets and has already demonstrated the ability to offer visible results of cleaner, firmer and more radiant skin in as little as five minutes twice a week. The addition of ageLOC technology to this core product lineup is a natural fit. “We believe that by slowing an inherent source of aging in the epidermis, the skin benefits are visibly obvious,” said Helen Knaggs, Ph.D., vice president of Nu Skin global research and development. “A recent consumer use study demonstrates the visible benefits of this strategy.”
ageLOC Consumer Use Study
While ageLOC technology is designed to help prevent the visible effects of aging at their source, a recent consumer use study also identifies a significant corrective benefit. Study participants who used the Galvanic Spa Facial Gels with ageLOC reported greater improvements in skin attributes than those using the original Galvanic gels. Participants in the ageLOC group graded their skin texture 30 percent better than did the participants using the original gels. Similarly, they believed their results for skin health were 20 percent better, improvement in skin clarity was 13 percent more and improvement in skin brightness was 11 percent more.
About the Galvanic Spa System
Galvanic Spa Facial Gels with ageLOC are used in combination with the Galvanic Spa device. The Nu Skin Galvanic Spa System II includes a patented, handheld device that uses self-adjusting, low-level galvanic currents to help transport key ingredients to the skin for a revived and rejuvenated appearance. Galvanic treatments operate on the basic principle that like charges repel and opposites attract. When paired with proprietary Nu Skin products formulated with either a negative or positive charge, and when programmed with the same polarity, the Nu Skin Galvanic Spa instrument repels treatment products, assisting with the delivery of active ingredients to the skin. The Galvanic Pre-Treat Gel has a negative charge, and the Treatment Gel with ageLOC technology has a positive charge.
About ageLOC Technology
ageLOC technology is the result of collaborative research from scientists at Nu Skin and Purdue University, and is designed to inhibit a newly identified age-related enzyme found on external cell membranes, including in the epidermis. Age-related NADH oxidase, or arNOX, is an internal free radical generator that increases in activity as you age. In a clinical study conducted with Stanford University, clinical graders concluded that study participants with higher levels of arNOX appeared an average of seven years older, while participants with lower levels of arNOX appeared an average of seven years younger. For more details: http://www.prnewswire.com/mnr/nuskin/35618/
The Appearance Of Aging And Arnox
Scientists from Nu Skin Enterprises Inc. presented the results of a breakthrough study at the 25th International Federation of Societies of Cosmetic Chemists Congress (IFSCC) in Barcelona revealing a correlation between levels of a newly identified age-related enzyme, arNOX, and a person’s appearance. The study, conducted at Stanford University, demonstrated that women with higher activity levels of arNOX appeared an average of seven years older than their chronological age, while women with decreased activity levels of the enzyme appeared to be seven years younger than their actual age, on average. “Demonstrating arNOX as a source of certain visible signs of aging validates our strategic focus of attacking the sources of aging,” said Joe Chang, Ph.D., chief scientific officer at Nu Skin. “Merely repairing damage to the skin from environmental and mechanical stresses is no longer sufficient for savvy consumers.” “The ground-breaking conclusions in this research, combined with trends of an aging demographic, lead us to believe that there is sizable market potential for a product that inhibits arNOX activity, and thus slows the appearance of certain signs of aging,” said Ashok Pahwa, chief marketing officer at Nu Skin. “Additionally, the lines between personal care and nutrition are blurring,” continued Pahwa. “Savvy consumers are increasingly aware of the link between nutrition and beauty, and industry analysts report that products to postpone aging will perhaps witness the strongest demand in upcoming years.” Nu Skin currently holds patents and exclusive patent rights to arNOX inhibitors and plans to commercialize the scientific advances under its new product platform branded as ageLOC. The first topical ageLOC application will be launched later this month. Because the arNOX enzyme is present throughout the body, not just in the epidermis, the company is also conducting additional studies to better understand the broader applications of ageLOC technology in nutritional supplementation.
Recommended Prospecting System
Translator
By N2H Recommended Prospecting System